| Gene symbol | TNFRSF17 | Synonyms | BCM, BCMA, CD269, TNFRSF13A | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p13.13 | dbXrefs | |
| Description | TNF receptor superfamily member 17 | ||||
| Gene symbol | SDC1 | Synonyms | CD138, SDC, SYND1, syndecan | Type of gene | protein-coding |
| Chromosome | 2 | Map location | 2p24.1 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | syndecan 1 | ||||
| Gene symbol | CD38 | Synonyms | ADPRC 1, ADPRC1, cADPR1 | Type of gene | protein-coding |
| Chromosome | 4 | Map location | 4p15.32 | dbXrefs | |
| Gene perturbation-related omics dataset | PertOrg | ||||
| Description | CD38 molecule | ||||
| Gene symbol | NCAM1 | Synonyms | CD56, MSK39, NCAM | Type of gene | protein-coding |
| Chromosome | 11 | Map location | 11q23.2 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | neural cell adhesion molecule 1 | ||||
| GTO ID | GTC1775 |
| Trial ID | NCT03271632 |
| Disease | Multiple Myeloma |
| Altered gene | BCMA|CD38|CD56|CD138 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CAR-T cells |
| Phase | Phase1|Phase2 |
| Recruitment status | Unknown |
| Title | Multi-CAR T Cell Therapy in the Treatment of Multiple Myeloma |
| Year | 2017 |
| Country | China |
| Company sponsor | Shenzhen Geno-Immune Medical Institute |
| Other ID(s) | GIMI-IRB-17013 |
| Cohort 1 | |||||||||
|
|||||||||